| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 08/15/2023 |
| 08/16/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 25k | $8.90 | $222.5k | | 08/15/2023 |
| 08/15/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 08/15/2023 |
| 08/15/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 4.7k | $9.19 | $43.4k | | 08/15/2023 |
| 08/15/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 25k | $9.27 | $231.8k | | 08/15/2023 |
| 07/19/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 2k | $14.36 | $28.6k | | 07/18/2023 |
| 07/19/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 13.2k | $15.36 | $202k | | 07/18/2023 |
| 07/19/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 9.9k | $16.00 | $157.7k | | 07/18/2023 |
| 07/19/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 07/18/2023 |
| 07/18/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 07/18/2023 |
| 07/18/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 24.5k | $13.62 | $333.8k | | 07/18/2023 |
| 07/18/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 500 | $14.05 | $7k | | 07/18/2023 |
| 06/14/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 06/13/2023 |
| 06/14/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 25k | $10.07 | $251.8k | | 06/13/2023 |
| 06/13/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Exercise | Stock Option (Right to Buy) | 37.5k | $2.22 | $83.2k | | 06/13/2023 |
| 06/13/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 25k | $9.93 | $248.3k | | 06/13/2023 |
| 05/15/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 4.8k | $5.60 | $26.7k | | 05/15/2023 |
| 11/15/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 1.1k | $11.86 | $12.6k | | 11/15/2022 |
| 08/15/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 1.1k | $12.96 | $13.8k | | 08/15/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 58.3k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 678 | $11.40 | $7.7k | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 58.3k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Payment of Exercise | Class A Common Stock | 678 | $11.40 | $7.7k | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (Right to Buy) | 116.7k | $11.40 | $1.3M | | 02/04/2022 |
| 02/04/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (Right to Buy) | 3.9k | $11.40 | $44.6k | | 02/04/2022 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Stock Option (Right to Buy) | 820.3k | $2.22 | $1.8M | | 04/20/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Stock Option (Right to Buy) | 1.5M | $2.22 | $3.3M | | 04/20/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Common Stock | 149.1k | $0.00 | $0 | | 04/20/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Other (disposition) | Common Stock | 528.8k | $0.00 | $0 | | 04/20/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Other (acquisition) | Class A Common Stock | 528.8k | $0.00 | $0 | | 04/20/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Series D Preferred Stock | 149.1k | $0.00 | $0 | | 04/20/2021 |